000 | 01601 a2200457 4500 | ||
---|---|---|---|
005 | 20250512200600.0 | ||
264 | 0 | _c19860103 | |
008 | 198601s 0 0 eng d | ||
022 | _a0065-2571 | ||
024 | 7 |
_a10.1016/0065-2571(83)90019-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCooney, D A | |
245 | 0 | 0 |
_aStudies on the mechanism of action of tiazofurin metabolism to an analog of NAD with potent IMP dehydrogenase-inhibitory activity. _h[electronic resource] |
260 |
_bAdvances in enzyme regulation _c1983 |
||
300 |
_a271-303 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 |
_aGuanosine Triphosphate _xmetabolism |
650 | 0 | 4 |
_aIMP Dehydrogenase _xantagonists & inhibitors |
650 | 0 | 4 |
_aKetone Oxidoreductases _xantagonists & inhibitors |
650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
650 | 0 | 4 | _aMass Spectrometry |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNAD _xanalogs & derivatives |
650 | 0 | 4 |
_aRibavirin _xanalogs & derivatives |
650 | 0 | 4 |
_aRibonucleosides _xpharmacology |
650 | 0 | 4 | _aSpectrophotometry |
700 | 1 | _aJayaram, H N | |
700 | 1 | _aGlazer, R I | |
700 | 1 | _aKelley, J A | |
700 | 1 | _aMarquez, V E | |
700 | 1 | _aGebeyehu, G | |
700 | 1 | _aVan Cott, A C | |
700 | 1 | _aZwelling, L A | |
700 | 1 | _aJohns, D G | |
773 | 0 |
_tAdvances in enzyme regulation _gvol. 21 _gp. 271-303 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/0065-2571(83)90019-5 _zAvailable from publisher's website |
999 |
_c6152798 _d6152798 |